EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway

Rui Yu iD, Dandi Gao, Jiali Bao, Ronghao Sun, Mengqi Cui, Yunyun Mao, Kai Li, Enbo Hu, Yanfang Zhai, Yanhong Liu, Yuemei Gao, Ting Xiao und 3 weitere

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms24043818 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Rui Yu und 14 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China. Hauptthemen laut MEDLINE: Idiopathic Pulmonary Fibrosis, Lung Neoplasms, Thymosin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central Universities, Nankai University; Tianjin Science and Technology Program; Foundation of Organ Fibrosis Drug gabil…, Fundamental Research Funds for the Central Universities, Nankai University, Tianjin Science and Technology Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, fibrotic interstitial lung disease of unknown etiology. At present, the mortality rate of the deadly disease is still very high, while the existing treatments only delay the progression of the disease and improve the quality of life of patients. Lung cancer (LC) is the most fatal disease in the world. In recent years, IPF has been considered to be an independent risk factor for the development of LC. The incidence of lung cancer is increased in the patients with IPF and the mortality is also significantly increased in the patients inflicted with the two diseases. In this study, we evaluated an animal model of pulmonary fibrosis complicated with LC by implanting LC cells orthotopically into the lungs of mice several days after bleomycin induction of the pulmonary fibrosis in the same mice. In vivo studies with the model showed that exogenous recombinant human thymosin beta 4 (exo-rhTβ4) alleviated the impairment of lung function and severity of damage of the alveolar structure by the pulmonary fibrosis and inhibited the proliferation of LC tumor growth. In addition, in vitro studies showed that exo-rhTβ4 inhibited the proliferation and migration of A549 and Mlg cells. Furthermore, our results also showed that rhTβ4 could effectively inhibit the JAK2-STAT3 signaling pathway and this might exert an anti-IPF-LC effect. The establishment of the IPF-LC animal model will be helpful for the development of drugs for the treatment of IPF-LC. Exogenous rhTβ4 can be potentially used for the treatment of IPF and LC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Idiopathic Pulmonary FibrosisLung NeoplasmsThymosinAnimalsHumansMiceBleomycinJanus Kinase 2LungQuality of LifeSignal TransductionSTAT3 Transcription Factor

Stichwörter der Autor:innen

IPF-LCJAK2/STAT3Tβ4

Substanzen

BleomycinJAK2 protein, humanJanus Kinase 2STAT3 protein, humanSTAT3 Transcription FactorThymosin

Autor:innen und Institutionen

  • Institute of Biotechnology, Academy of Military Medical Sciences, Beijing 100071, China.
  • State Key Laboratory of Medicinal Chemical Biology, College of Pharmacy and Tianjin Key Laboratory of Molecular Drug Research, Nankai University, Tianjin 300353, China.

ORCID-Profile: Rui Yu, Honggang Zhou

Förderung

  • the Fundamental Research Funds for the Central Universities, Nankai University; Tianjin Science and Technology Program; Foundation of Organ Fibrosis Drug gabil…
  • Fundamental Research Funds for the Central Universities, Nankai University
  • Tianjin Science and Technology Program
  • Foundation of Organ Fibrosis Drug gability Joint Research Centre of Nankai and Guokaixingcheng
  • 111 Project B20016

Zitieren

APA

Yu, R., Gao, D., Bao, J., Sun, R., Cui, M., Mao, Y., Li, K., Hu, E., Zhai, Y., Liu, Y., Gao, Y., Xiao, T., Zhou, H., Yang, C., & Xu, J. (2023). Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms24043818

Vancouver

Yu R, Gao D, Bao J, Sun R, Cui M, Mao Y, et al. Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms24043818

BibTeX
@article{Yu2023,
  author = {Yu, Rui and Gao, Dandi and Bao, Jiali and Sun, Ronghao and Cui, Mengqi and Mao, Yunyun and Li, Kai and Hu, Enbo and Zhai, Yanfang and Liu, Yanhong and Gao, Yuemei and Xiao, Ting and Zhou, Honggang and Yang, Cheng and Xu, Junjie},
  title = {Exogenous Thymosin Beta 4 Suppresses IPF-Lung Cancer in Mice: Possibly Associated with Its Inhibitory Effect on the JAK2/STAT3 Signaling Pathway},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms24043818}
}
Kostenlos starten →